Paratek’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Paratek is a biopharmaceutical company that develops antibiotic drugs to treat bacterial pneumonia in adults. Read more

Evan Loh's photo - CEO of Paratek

CEO

Evan Loh

CEO Approval Rating

90/100

Founded:

1996

Status:

PublicNASDAQPRTK

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Melinta is a top competitor of Paratek. Melinta was founded in Morristown, New Jersey} in 2000. Melinta competes in the Pharmaceuticals industry. Compared to Paratek, Melinta generates $66.3M more revenue.

Moderna is Paratek's #2 competitor. Moderna is headquartered in Cambridge, Massachusetts, and was founded in 2010. Moderna competes in the Biotechnology field. Moderna generates 351% the revenue of Paratek.

Achillion has been one of Paratek's top competitors. Achillion is a Private company that was founded in 1998 in New Haven, Connecticut. Like Paratek, Achillion also competes in the Pharmaceuticals industry. Compared to Paratek, Achillion has 45 fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Spero a competitor of Paratek?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$30.1M

Paratek's revenue is the ranked 15th among it's top 10 competitors. The top 10 competitors average 1.5B. Over the last four quarters, Paratek's revenue has grown by 137.1%. Specifically, in Q2 2020's revenue was $9.3M; in Q1 2020, it was $7.9M; in Q4 2019, it was $9M; in Q3 2019, Paratek's revenue was $3.9M.

Acquisitions

No recent acquisitions found related to Paratek

Paratek Funding History

$40M$133M

Since Paratek was founded in 1996, it has participated in 2 rounds of funding. In total Paratek has raised $133.0M. Paratek's last funding round was on Jun 2014 for a total of $93.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jun 2014
$93M
Series A
Jun 2008
$40M

Aisling Capital

Total Funding: $133M

Since Paratek was founded in 1996, it has participated in 2 rounds of funding. In total Paratek has raised $133.0M. Paratek's last funding round was on Jun 2014 for a total of $93.0M

Investments

No recent investments found related to Paratek

Paratek News

August 12, 2020MarketScreener

Wedbush Conference August 2020

(marketscreener.com) QIDP ...https://www.marketscreener.com/PARATEK-PHARMACEUTICALS-18426416/news/Par... See more »
August 10, 2020NewsOk

2Q Earnings Snapshot

BOSTON (AP) _ Paratek Pharmaceuticals Inc. (PRTK) on Monday reported a loss of $23.1 million in its s... See more »
June 15, 2020Market Exclusive

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Submission of Matters to a Vote of Security Holders

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Submission of Matters to a Vote of Security ... See more »
June 4, 2020FiercePharma

As U.S. calls for stateside manufacturing, antibiotic maker Paratek gambles on 'onshoring' effort

As U.S. calls for stateside manufacturing, antibiotic maker Paratek gambles on 'onshoring' effort kbl... See more »
May 28, 2020Benzinga

Paratek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare Conference

BOSTON, May 28, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), a commercial-st... See more »
May 14, 2020Seeking Alpha

Paratek Plods Along

May 13, 2020MarketScreener

Bank of America Securities 2020 Health Care Conference

(marketscreener.com) QIDP ABSSSI - QIDP ...https://www.marketscreener.com/PARATEK-PHARMACEUTICALS-184... See more »

Paratek Press Releases

February 13, 2020GlobeNewswire

Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020

BOSTON, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-... See more »
November 12, 2019GlobeNewswire

Paratek Pharmaceuticals Generates Net Revenues of $3.9 Million in the Third Quarter of 2019

-- Third Quarter 2019 NUZYRA® (omadacycline) Net Sales increased 82% versus the Prior Quarter to $3.1... See more »
November 4, 2019GlobeNewswire

Paratek Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019

BOSTON, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-... See more »
September 4, 2019GlobeNewswire

Paratek Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference

BOSTON, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial... See more »
August 6, 2019GlobeNewswire

Paratek Pharmaceuticals Generates Net Revenues of $2.0 Million in the Second Quarter of 2019

-- NUZYRA® (omadacycline) Net Sales increased 26% to $1.7 Million in the Second Quarter of 2019 -- --... See more »
July 29, 2019GlobeNewswire

Paratek Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 6, 2019

BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-... See more »
May 8, 2019GlobeNewswire

Paratek's NUZYRA (omadacycline) Generates Net Sales of $1.3 Million in the First Eight Weeks on the U.S. Market

-- Approximately One Third of Commercial Lives in U.S. had Access to NUZYRA by the End of the First Q... See more »

Headquarters

75 Park Plz Ste 4 4th Floor

Boston, Massachusetts02116

1-617-807-6600

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Paratek is a biopharmaceutical company that develops antibiotic drugs to treat bacterial pneumonia in adults. Paratek was founded in 1996. Paratek's headquarters is located in Boston, Massachusetts, USA 02116. It has raised 133.0M in 2 rounds. The lat...

CEO

Paratek's CEO, Evan Loh, currently has an approval rating of 90%. Paratek's primary competitors are Melinta, Moderna & Achillion.

Website

paratekpharma.com

Frequently Asked Questions about Paratek

  1. When was Paratek founded?

    Paratek was founded in 1996
  2. Who is Paratek's CEO?

    Paratek's CEO is Evan Loh
  3. How much revenue does Paratek generate?

    Paratek generates $30.1M in revenue
  4. How much funding does Paratek have?

    Paratek has historically raised $133M in funding
  1. Where is Paratek's headquarters?

    Paratek's headquarters is in Boston Massachusetts, USA
  2. How many employees does Paratek have?

    Paratek has 101 employees
  3. What sector does Paratek operate in?

    Paratek is in Pharmaceuticals
  4. Who are Paratek's competitors?

    Paratek's top competitors are Melinta, Moderna, Achillion